Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients

CTCL is a cancer of skin homing T cells with variants that include leukemic CTCL (L-CTCL), a malignancy of central memory T cells (T(CM)), and mycosis fungoides (MF), a malignancy of skin resident effector memory T cells (T(EM)). We report that low-dose alemtuzumab (αCD52) effectively treated patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Clark, Rachael A., Watanabe, Rei, Teague, Jessica E., Schlapbach, Christoph, Tawa, Marianne C., Adams, Natalie, Dorosario, Andrew A., Chaney, Keri S., Cutler, Corey S., LeBoeuf, Nicole R., Carter, Joi B., Fisher, David C., Kupper, Thomas S.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3373186/
https://ncbi.nlm.nih.gov/pubmed/22261031
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3003008
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items